We are live on ! Find out more
PIM

Ponoi II Management Portfolio holdings

AUM $38.3M
1-Year Est. Return 32.02%
This Fund
S&P 500
This Quarter Est. Return
+40.81%
1 Year Est. Return
-32.02%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
–
Cap. Flow
+$122M
Cap. Flow %
88.76%
Top 10 Hldgs %
100%
Holding
5
New
5
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$39.6M
2
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$28.4M
3
RVMD icon
Revolution Medicines
RVMD
+$27.1M
4
NRIX icon
Nurix Therapeutics
NRIX
+$22.7M
5
RAPT
RAPT Therapeutics
RAPT
+$3.95M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNST
1
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$45.3M 33.03%
+1,574,229
New +$39.6M
NGM
2
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$39.4M 28.68%
+1,298,908
New +$28.4M
RVMD icon
3
Revolution Medicines
RVMD
$39.6B
$27.1M 19.76%
+685,011
New +$27.1M
NRIX icon
4
Nurix Therapeutics
NRIX
$2.4B
$22.6M 16.44%
+686,274
New +$22.7M
RAPT
5
DELISTED
RAPT Therapeutics
RAPT
$2.87M 2.09%
+18,175
New +$3.95M

Similar funds

FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
SEM
Spectrum Equity Management San Francisco, California $39.1M AUM 63.69% 1-Year Est. Return
MCMI
Matrix China Management III Grand Cayman, Cayman Islands $39.3M AUM
LCM
LH Capital Markets New York $39.4M AUM 14.61% 1-Year Est. Return
HLC
Hunt Lane Capital New York $39.6M AUM 58.74% 1-Year Est. Return
KCGDR
Kiron Capital Gestao de Recursos Sao Paulo, Brazil $36.9M AUM 49.85% 1-Year Est. Return
ALFIA
Accel Leaders Fund II Associates Palo Alto, California $36.6M AUM 58.14% 1-Year Est. Return
PSCM
Prince Street Capital Management New York $40.3M AUM 0.66% 1-Year Est. Return

Ponoi II Management's Q4 2020 Portfolio in Review

Q4 2020 is the first quarter with a 13F filing on record for Ponoi II Management, which disclosed 5 positions worth $137M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Constellation Pharmaceuticals, Inc.: 1,574,229 shares worth $45.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ponoi II Management's largest Q4 2020 buy was Constellation Pharmaceuticals, Inc.: 1,574,229 shares worth $45.3M.
  • Ponoi II Management's ten largest holdings make up 100% of its $137M portfolio in Q4 2020.
  • Ponoi II Management disclosed 5 positions in Q4 2020, its first 13F filing on record.

Based on Ponoi II Management's 13F filing for Q4 2020, filed 16 Feb 2021.